SCM
Soleus Capital Management’s Y-mAbs Therapeutics YMAB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.58M | Hold |
349,982
| – | – | 0.1% | 78 |
|
|
2025
Q1 | $1.55M | Hold |
349,982
| – | – | 0.11% | 65 |
|
|
2024
Q4 | $2.74M | Sell |
349,982
-50,000
| -13% | -$392K | 0.17% | 64 |
|
|
2024
Q3 | $5.26M | Sell |
399,982
-248,000
| -38% | -$3.26M | 0.41% | 59 |
|
|
2024
Q2 | $7.83M | Buy |
647,982
+77,000
| +13% | +$930K | 0.69% | 46 |
|
|
2024
Q1 | $9.28M | Buy |
570,982
+413,800
| +263% | +$6.73M | 0.69% | 44 |
|
|
2023
Q4 | $1.07M | Hold |
157,182
| – | – | 0.12% | 60 |
|
|
2023
Q3 | $857K | Hold |
157,182
| – | – | 0.08% | 81 |
|
|
2023
Q2 | $1.07M | Buy |
157,182
+70,000
| +80% | +$475K | 0.12% | 84 |
|
|
2023
Q1 | $437K | Hold |
87,182
| – | – | 0.05% | 75 |
|
|
2022
Q4 | $425K | Hold |
87,182
| – | – | 0.06% | 70 |
|
|
2022
Q3 | $1.26M | Sell |
87,182
-49,000
| -36% | -$706K | 0.17% | 67 |
|
|
2022
Q2 | $2.06M | Sell |
136,182
-102,800
| -43% | -$1.56M | 0.32% | 59 |
|
|
2022
Q1 | $2.84M | Sell |
238,982
-71,512
| -23% | -$850K | 0.37% | 48 |
|
|
2021
Q4 | $5.03M | Buy |
310,494
+44,794
| +17% | +$726K | 0.5% | 36 |
|
|
2021
Q3 | $7.58M | Buy |
265,700
+121,400
| +84% | +$3.46M | 1.18% | 27 |
|
|
2021
Q2 | $4.88M | Buy |
+144,300
| New | +$4.88M | 0.75% | 27 |
|